Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2017 / Honorees / Boris Stanzel

Boris Stanzel

  • Profile

About Boris Stanzel

Boris Stanzel

Consultant Retina Specialist and Director, Macula Centre, Knappschaft Eye Hospital Sulzbach, Saarbrücken Germany; Group leader, Clinical Stem Cell Technology, Fraunhofer Institute for Biomedical Technology, Saarbrücken-Sulzbach, Germany; Scientific Consultant, National Eye Institute, Bethesda, MD, USA

Stanzel gained international renown for his transplantation of retinal pigment epithelium into the subretinal space of rabbits – a first in a large-eyed animal model, followed closely by successful transplantation into pigs. Recently, he and his colleagues at the Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI), the NEI and Tampere University, Finland, have successfully created a non-human primate model platform, guided by intraoperative OCT, for stem cell-based RPE replacement therapy evaluation – bringing this modality a step closer to clinical use. He credits his time at SNEC/SERI as critical to this development. His next goal is to initiate a European cell replacement therapy clinical trial.

One nominator said, “Boris is one of the most gifted researchers around, and his work is truly ground-breaking. I am sure his monkey work evaluating the surgical macular dynamics of cell replacement strategies in macular degeneration will prove to be an important milestone in stem cell research.”


Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: